3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Nasopharyngeal Carcinoma
26
Prostatic Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Nasopharyngeal Neoplasms
6
Head and Neck Neoplasms
6
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Oropharyngeal Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Tongue Neoplasms
2
Salivary Gland Neoplasms
2
Radiation Injuries
2
Neurotoxicity Syndromes
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Carcinoma
2
Brain Neoplasms
2
Astrocytoma
2
Vaginal Neoplasms
1
Thoracic Neoplasms
1
Stage II Prostate Adenocarcinoma AJCC v7
1
Sarcoma
1
Precancerous Conditions
1
Postoperative Complications
1
Papillomavirus Infections
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Adenocarcinoma
1
Ototoxicity
1
Oligodendroglioma
1
Interventions
Gemcitabine
2
Taxes
1
Radiotherapy, Intensity-Modulated
1
Irinotecan
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pancreatic Adenocarcinoma
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT06250972
2025-08-07
PTCA199-11
Fudan University
Phase 3
Recruiting
210 enrolled